Panel: Targeted approaches to combinations, what’s working?
Wednesday, September 30, 2020 8:20 PM to 9:20 PM · 1 hr. (Africa/Abidjan)
Cancer & Immunotherapy
Information
· What strategies can we use to identify the best combinations?
o Using immunology as a guide?
o Combinations of any active compound?
· What are the major mechanisms we need to focus on?
· How successful have targeted combinations been so far?
o IO-IO/ IO-Non-IO combos / Targeting the TME / Angiogenesis inhibitors / Standard of care agents
· What are the best biomarkers for combination studies?
· What major challenges remain?
Topics
Topics
BiomarkersCheckpoint inhibitorsCombination therapy
Session type
Session type
Panels